AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16182832 — intervention group
Group type: EXPERIMENTAL
Intervention: tacrolimus and MMF
Number of subjects: 205
Study 16182832 — intervention group
Group type: EXPERIMENTAL
Intervention: cyclosporine microemulsion (CsA‐ME) and MMF
Number of subjects: 205
Study 16182832 — intervention group
Group type: COMPARATOR
Intervention: corticosteroid therapy (control group)
Number of subjects: 205
Study 11509496 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine monohydrate (20 g/day for 5 days followed by 5 g/day for 3-4 days)
Number of subjects: 27
Study 11509496 — intervention group
Group type: COMPARATOR
Intervention: Placebo (glucose polymers)
Number of subjects: 27
Study 9506757 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous cocaine (0.2 mg/kg)
Number of subjects: 12
Study 7522315 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical corticosteroids (0.1% fluorometholone for 6 months)
Number of subjects: 86
Study 7522315 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasmin inhibitors (aprotinin 40 IU/ml for 3 weeks)
Number of subjects: 86
Study 7522315 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 86
Study 7522315 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasmin inhibitors (aprotinin)
Number of subjects: 86
Study 3351000 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluphenazine decanoate 12.5 mg intramuscularly every 2 weeks
Number of subjects: 12
Study 3351000 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 3351000 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluphenazine decanoate withdrawal
Number of subjects: 12
Study 30256319 — intervention group
Group type: EXPERIMENTAL
Intervention: Spring-loaded injector (NIO)
Number of subjects: 64
Study 30256319 — intervention group
Group type: EXPERIMENTAL
Intervention: Battery power drill (EZ-IO)
Number of subjects: 64
Study 30256319 — intervention group
Group type: EXPERIMENTAL
Intervention: Ease of use (spring-loaded injector)
Number of subjects: 64
Study 30256319 — intervention group
Group type: EXPERIMENTAL
Intervention: Ease of use (battery power drill)
Number of subjects: 64
Study 31780096 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple respiratory viral infections (≥2 strains)
Number of subjects: 270
Study 31780096 — intervention group
Group type: COMPARATOR
Intervention: Single or nondetectable viral infection
Number of subjects: 270
Study 29852208 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 62
Study 29852208 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 28231596 — intervention group
Group type: EXPERIMENTAL
Intervention: Senso-Motoric Training (SMT) - 30 minutes per day
Number of subjects: 43
Study 28231596 — intervention group
Group type: COMPARATOR
Intervention: Conventional Strength Training (KT) - 30 minutes per day
Number of subjects: 43
Study 28231596 — intervention group
Group type: EXPERIMENTAL
Intervention: Senso-Motoric Training (SMT)
Number of subjects: 43
Study 28231596 — intervention group
Group type: COMPARATOR
Intervention: Conventional Strength Training (KT)
Number of subjects: 43
Study 23425550 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fluoride public water supply in intervention villages (A-D)
Number of subjects: 480
Study 21839757 — intervention group
Group type: EXPERIMENTAL
Intervention: Theobromine (700 mg)
Number of subjects: 24
Study 21839757 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (120 mg)
Number of subjects: 24
Study 21839757 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of caffeine and theobromine
Number of subjects: 24
Study 21839757 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 19453998 — intervention group
Group type: EXPERIMENTAL
Intervention: rapamycin
Number of subjects: 46
Study 19453998 — intervention group
Group type: COMPARATOR
Intervention: tacrolimus
Number of subjects: 46
Study 19453998 — intervention group
Group type: COMPARATOR
Intervention: mycophenolate mofetil
Number of subjects: 46
Study 16712638 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint attention intervention
Number of subjects: 58
Study 16712638 — intervention group
Group type: EXPERIMENTAL
Intervention: Symbolic play intervention
Number of subjects: 58
Study 16712638 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 58
Study 15577539 — intervention group
Group type: EXPERIMENTAL
Intervention: Emtricitabine 200 mg QD
Number of subjects: 440
Study 15577539 — intervention group
Group type: COMPARATOR
Intervention: Lamivudine 150 mg BID
Number of subjects: 440
Study 11354919 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical penciclovir applied every 2 hours during waking hours
Number of subjects: 40
Study 11354919 — intervention group
Group type: COMPARATOR
Intervention: Topical acyclovir applied every 2 hours during waking hours
Number of subjects: 40
Study 9241092 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine with Valproate (N=10)
Number of subjects: 27
Study 9241092 — intervention group
Group type: COMPARATOR
Intervention: Carbamazepine alone (N=17)
Number of subjects: 27
Study 8173850 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAID plus placebo TENS
Number of subjects: 36
Study 8173850 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS plus placebo drug
Number of subjects: 36
Study 8173850 — intervention group
Group type: COMPARATOR
Intervention: Double placebo
Number of subjects: 36
Study 8173850 — intervention group
Group type: EXPERIMENTAL
Intervention: PIPER ratings
Number of subjects: 36
Study 3135588 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenoxymethylpenicillin for 1 week
Number of subjects: 62
Study 3135588 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenoxymethylpenicillin for 3 months
Number of subjects: 62
Study 3135588 — intervention group
Group type: COMPARATOR
Intervention: No systemic antibiotics
Number of subjects: 62
Study 31565730 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard treatment for fit patients
Number of subjects: 0
Study 31565730 — intervention group
Group type: EXPERIMENTAL
Intervention: Best supportive or palliative care for frail patients
Number of subjects: 0
Study 31565730 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite endpoints incorporating geriatric assessment
Number of subjects: 0
Study 31565730 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized clinical trial
Number of subjects: 0
Study 31565730 — intervention group
Group type: EXPERIMENTAL
Intervention: Observational study
Number of subjects: 0
Study 28332360 — intervention group
Group type: COMPARATOR
Intervention: Entecavir (ETV)
Number of subjects: 60
Study 28332360 — intervention group
Group type: EXPERIMENTAL
Intervention: Telbivudine (LdT)
Number of subjects: 60
Study 25451631 — intervention group
Group type: EXPERIMENTAL
Intervention: Harmonic scalpel hemorrhoidectomy (HSH)
Number of subjects: 99
Study 25451631 — intervention group
Group type: COMPARATOR
Intervention: Stapler hemorrhoidopexy (SH)
Number of subjects: 99
Study 24660605 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional therapy plus Xuebijing (XBJ) injection
Number of subjects: 63
Study 24660605 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy alone
Number of subjects: 63
Study 21224045 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 784
Study 21224045 — intervention group
Group type: COMPARATOR
Intervention: High ERCC1 scores
Number of subjects: 784
Study 18203764 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept and Methotrexate
Number of subjects: 0
Study 18203764 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiographic progression categories (negative, zero, minor, greater progression)
Number of subjects: 0
Study 22143683 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 laser
Number of subjects: 50
Study 22143683 — intervention group
Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser
Number of subjects: 50
Study 15483085 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone (40 mg daily)
Number of subjects: 15
Study 15483085 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone (40 mg daily) + hCG
Number of subjects: 15
Study 15483085 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone (40 mg daily) without hCG (P only)
Number of subjects: 15
Study 15483085 — intervention group
Group type: COMPARATOR
Intervention: Control group (GnRH agonists)
Number of subjects: 15
Study 12860217 — intervention group
Group type: EXPERIMENTAL
Intervention: TEE guided strategy with short‐term anticoagulation
Number of subjects: 1222
Study 12860217 — intervention group
Group type: COMPARATOR
Intervention: Conventional strategy
Number of subjects: 1222
Study 12860217 — intervention group
Group type: EXPERIMENTAL
Intervention: TEE guided strategy
Number of subjects: 1222
Study 12860217 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 1222
Study 9794851 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomised controlled trials (RCTs)
Number of subjects: 11
Study 9794851 — intervention group
Group type: EXPERIMENTAL
Intervention: Adequately concealed random allocation
Number of subjects: 11
Study 9794851 — intervention group
Group type: COMPARATOR
Intervention: Non-randomly selected control groups
Number of subjects: 11
Study 9794851 — intervention group
Group type: COMPARATOR
Intervention: Inadequately concealed random allocation
Number of subjects: 11
Study 8530808 — intervention group
Group type: EXPERIMENTAL
Intervention: Enterococcus faecium (SF68)
Number of subjects: 40
Study 8530808 — intervention group
Group type: COMPARATOR
Intervention: lactulose
Number of subjects: 40
Study 1023952 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.125%
Number of subjects: 31
Study 1023952 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.25%
Number of subjects: 31
Study 1023952 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.5%
Number of subjects: 31
Study 1023952 — intervention group
Group type: EXPERIMENTAL
Intervention: Lignocaine 0.5%
Number of subjects: 31
Study 1023952 — intervention group
Group type: EXPERIMENTAL
Intervention: Lignocaine 1%
Number of subjects: 31
Study 1023952 — intervention group
Group type: EXPERIMENTAL
Intervention: Lignocaine 2%
Number of subjects: 31
Study 30535537 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide SC depot 10 mg q2w
Number of subjects: 12
Study 30535537 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide SC depot 20 mg q4w
Number of subjects: 12
Study 30535537 — intervention group
Group type: COMPARATOR
Intervention: Octreotide IM
Number of subjects: 12
Study 30535537 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide SC depot
Number of subjects: 12
Study 28768835 — intervention group
Group type: EXPERIMENTAL
Intervention: Total dairy consumption (≥14 servings/week)
Number of subjects: 2809
Study 28768835 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat dairy consumption (≥14 servings/week)
Number of subjects: 2809
Study 28768835 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat dairy consumption (≥14 servings/week)
Number of subjects: 2809
Study 28768835 — intervention group
Group type: EXPERIMENTAL
Intervention: Cheese consumption (≥4 servings/week)
Number of subjects: 2809
Study 25137296 — intervention group
Group type: EXPERIMENTAL
Intervention: Orally ingested colloidal silver nanoproduct
Number of subjects: 0
Study 25137296 — intervention group
Group type: COMPARATOR
Intervention: Control (standardized probes for P450 enzyme classes)
Number of subjects: 0
Study 23261122 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treatment (scaling and root planing, extraction of hopeless teeth, local-delivery antibiotics)
Number of subjects: 53
Study 23261122 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treatment
Number of subjects: 53
Study 23261122 — intervention group
Group type: COMPARATOR
Intervention: Control (treatment after 6 months)
Number of subjects: 53
Study 21163915 — intervention group
Group type: EXPERIMENTAL
Intervention: Gadobenate dimeglumine
Number of subjects: 162
Study 21163915 — intervention group
Group type: COMPARATOR
Intervention: Gadopentetate dimeglumine
Number of subjects: 162
Study 18082778 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraosseous administration of morphine sulfate (5 mg bolus)
Number of subjects: 0
Study 18082778 — intervention group
Group type: COMPARATOR
Intervention: Intravenous administration of morphine sulfate (5 mg bolus)
Number of subjects: 0
Study 16820611 — intervention group
Group type: EXPERIMENTAL
Intervention: Angioplasty
Number of subjects: 190
Study 16820611 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 190
Study 16820611 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 190
Study 12635911 — intervention group
Group type: EXPERIMENTAL
Intervention: Distant future behavior predictions
Number of subjects: 0
Study 12635911 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-situational consistency predictions
Number of subjects: 0
Study 12635911 — intervention group
Group type: EXPERIMENTAL
Intervention: Information seeking about global dispositions
Number of subjects: 0
Study 12635911 — intervention group
Group type: EXPERIMENTAL
Intervention: Global causal attributions
Number of subjects: 0
Study 10710863 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 mu of streptokinase (SK) infused in half an hour
Number of subjects: 40
Study 10710863 — intervention group
Group type: COMPARATOR
Intervention: 1.5 mu of streptokinase (SK) infused in one hour
Number of subjects: 40
Study 10710863 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (1.5 mu in half an hour and 1.5 mu in one hour)
Number of subjects: 40
Study 8938608 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed wound suction drain placed deep to the lumbodorsal fascia before routine closure
Number of subjects: 200
Study 8938608 — intervention group
Group type: COMPARATOR
Intervention: No drain placed after the surgical procedure
Number of subjects: 200
Study 8938608 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed wound suction drain
Number of subjects: 200
Study 8938608 — intervention group
Group type: COMPARATOR
Intervention: No drain placed
Number of subjects: 200
Study 1543417 — intervention group
Group type: EXPERIMENTAL
Intervention: Iontophoresis of lidocaine hydrochloride
Number of subjects: 75
Study 1543417 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 2864484 — intervention group
Group type: EXPERIMENTAL
Intervention: Red blood cells (RBCs) from CMV seronegative donors (group A)
Number of subjects: 151
Study 2864484 — intervention group
Group type: COMPARATOR
Intervention: Red blood cells (RBCs) from random donors (group B)
Number of subjects: 151
Study 2864484 — intervention group
Group type: COMPARATOR
Intervention: No RBCs (group C)
Number of subjects: 151
Study 2864484 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased IgG titres with CMV-specific IgM antibody
Number of subjects: 151
Study 29543538 — intervention group
Group type: EXPERIMENTAL
Intervention: Saffron (30 ml per day for 8 weeks)
Number of subjects: 57
Study 29543538 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study 28701674 — intervention group
Group type: EXPERIMENTAL
Intervention: Resveratrol 100mg daily for 12 weeks
Number of subjects: 50
Study 28701674 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 26329806 — intervention group
Group type: EXPERIMENTAL
Intervention: Total annual costs per patient
Number of subjects: 258
Study 26329806 — intervention group
Group type: EXPERIMENTAL
Intervention: Inpatient healthcare use
Number of subjects: 258
Study 26329806 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient healthcare use
Number of subjects: 258
Study 26329806 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental productivity loss
Number of subjects: 258
Study 26329806 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of total costs between IBS and FAP/FAPS
Number of subjects: 258
Study 23149973 — intervention group
Group type: EXPERIMENTAL
Intervention: ACDF-plate group
Number of subjects: 52
Study 23149973 — intervention group
Group type: COMPARATOR
Intervention: ACDF-cage group
Number of subjects: 52
Study 21952996 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastic knee sleeve
Number of subjects: 74
Study 18475166 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-4 mg doxazosin (doxazosin group)
Number of subjects: 611
Study 18475166 — intervention group
Group type: COMPARATOR
Intervention: Control group (no add-on medication)
Number of subjects: 611
Study 16571152 — intervention group
Group type: EXPERIMENTAL
Intervention: cis‐9,trans‐11 (c9,t11) CLA
Number of subjects: 15
Study 16571152 — intervention group
Group type: EXPERIMENTAL
Intervention: trans‐10,cis‐12 (t10,c12) CLA
Number of subjects: 15
Study 16571152 — intervention group
Group type: COMPARATOR
Intervention: Olive oil (placebo)
Number of subjects: 15
Study 16571152 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 15
Study 14521253 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (2.5 mg/kg i.v.)
Number of subjects: 100
Study 14521253 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane (6%+50% N2O+50% O2) by inhalation
Number of subjects: 100
Study 12353420 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (ACE inhibitor) intake for 1 year
Number of subjects: 10
Study 12353420 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 10
Study 9574791 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol plus quinine
Number of subjects: 47
Study 9574791 — intervention group
Group type: COMPARATOR
Intervention: Quinine alone
Number of subjects: 47
Study 7930335 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive geriatric assessment in a geriatric day hospital
Number of subjects: 468
Study 3259441 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin acetate (dDAVP)
Number of subjects: 70
Study 3259441 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 31868776 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindful Self-Compassion Intervention
Number of subjects: 0
Study 31868776 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 0
Study 29649503 — intervention group
Group type: EXPERIMENTAL
Intervention: transcranial direct current stimulation (tDCS)
Number of subjects: 82
Study 29649503 — intervention group
Group type: EXPERIMENTAL
Intervention: multifocal tDCS (mftDCS)
Number of subjects: 82
Study 29649503 — intervention group
Group type: EXPERIMENTAL
Intervention: random noise stimulation (tRNS)
Number of subjects: 82
Study 29649503 — intervention group
Group type: COMPARATOR
Intervention: multifocal alternating current stimulation at 40 Hz (mftACS)
Number of subjects: 82
Study 29649503 — intervention group
Group type: COMPARATOR
Intervention: no-contact control group
Number of subjects: 82
Study 28929999 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive cognitive training (12 individual sessions of 60 to 90 minutes, once a week)
Number of subjects: 80
Study 24983307 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus with reduced exposure cyclosporine A
Number of subjects: 148
Study 24983307 — intervention group
Group type: COMPARATOR
Intervention: Enteric-coated mycophenolate sodium and standard-exposure cyclosporine A
Number of subjects: 148
Study 24983307 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 148
Study 23078120 — intervention group
Group type: EXPERIMENTAL
Intervention: Laboratory-confirmed influenza
Number of subjects: 3273
Study 23078120 — intervention group
Group type: EXPERIMENTAL
Intervention: Laboratory-confirmed respiratory viral infection other than influenza
Number of subjects: 3273
Study 23078120 — intervention group
Group type: EXPERIMENTAL
Intervention: Entero/rhinovirus
Number of subjects: 3273
Study 23078120 — intervention group
Group type: EXPERIMENTAL
Intervention: Age-related incidence of infections
Number of subjects: 3273
Study 21421506 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucocorticoid treatment (short-term low-dose)
Number of subjects: 87
Study 21421506 — intervention group
Group type: COMPARATOR
Intervention: Control group (lamivudine and routine integrated treatment)
Number of subjects: 87
Study 18060706 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal 17beta‐estradiol
Number of subjects: 24
Study 18060706 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline serum physiologic)
Number of subjects: 24
Study 16594908 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lipid-lowering therapy (niacin or lovastatin plus colestipol)
Number of subjects: 51
Study 16594908 — intervention group
Group type: COMPARATOR
Intervention: Conventional lipid-lowering therapy (diet +/- colestipol)
Number of subjects: 51
Study 12891467 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprotinin (1 million KIU) administered 15 minutes before delivery
Number of subjects: 84
Study 12891467 — intervention group
Group type: COMPARATOR
Intervention: No aprotinin
Number of subjects: 84
Study 10488974 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment with 30 mg beta-carotene and 25,000 IU retinyl palmitate
Number of subjects: 52
Study 10488974 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 15321345 — intervention group
Group type: EXPERIMENTAL
Intervention: TED stockings applied 1 h before spinal anaesthesia
Number of subjects: 50
Study 15321345 — intervention group
Group type: COMPARATOR
Intervention: No TED stockings applied
Number of subjects: 50
Study 1707218 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin (OFLX) 100 mg twice daily for 4 to 15 weeks in group A
Number of subjects: 48
Study 1707218 — intervention group
Group type: COMPARATOR
Intervention: Control group (group B) with no OFLX or other antibiotics
Number of subjects: 48
Study 1707218 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin (OFLX) in group A
Number of subjects: 48
Study 1707218 — intervention group
Group type: COMPARATOR
Intervention: Control group (group B)
Number of subjects: 48
Study 6182816 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific immunotherapy (hyposensitization) with partially purified timothy extract or two timothy major allergens
Number of subjects: 40
Study 6182816 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified, but implied as no treatment or different treatment)
Number of subjects: 40
Study 31127302 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent intervention (MI): each student received a daily healthy meal along with educational actions
Number of subjects: 1442